IL6R and COVID-19: In a study of Yang et al. [88], plasma-cell-free circulating RNAs (cfRNAs) profiles of COVID-19 patients showed, among others, lower levels of miR-451a when compared with healthy donors and a significantly higher mRNA expression of the IL-6R target.